Concepts and needs for expert rules and intrepretive reading of the antibiogram The EUCAST perspective - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Concepts and needs for expert rules and intrepretive reading of the antibiogram The EUCAST perspective

Description:

and ampicillin. Proteus mirabilis and nitrofurantoin or colistin ... E. faecalis resistant to ampicillin. Enterobacteriaceae resistant to carbapenems ... – PowerPoint PPT presentation

Number of Views:255
Avg rating:3.0/5.0
Slides: 23
Provided by: cwa52
Category:

less

Transcript and Presenter's Notes

Title: Concepts and needs for expert rules and intrepretive reading of the antibiogram The EUCAST perspective


1
Concepts and needs for expert rules and
intrepretive reading of the antibiogram The
EUCAST perspective
  • Derek Brown
  • Health Protection Agency
  • Addenbrookes Hospital, Cambridge

2
What is an expert rule?
  • Description of action to be taken, based on
    current evidence, in response to specific
    antimicrobial susceptibility test results

3
What is interpretive reading?
  • Inference of resistance mechanisms from
    susceptibility test results and interpretation of
    clinical susceptibility on the basis of the
    resistance mechanism
  • This is one type of expert rule

4
Types of expert rules
  • Intrinsic resistance
  • Exceptional phenotypes (mainly resistance)
  • Interpretive reading

5
Intrinsic resistance
  • Inherent (not acquired) resistance which is a
    characteristic of all or almost all
    representatives of the species.
  • Antimicrobial susceptibility testing unnecessary
    but may be done as part of panels of test agents.
  • Susceptible results should be viewed with
    caution
  • errors in identification or susceptibility
    testing
  • If susceptibility is confirmed the drug should be
    used with caution

6
Intrinsic resistance examples
  • Specific Gram-positive or Gram-negative agents
  • Enterobacteriaceae and glycopeptides
  • Enterococci and fusidic acid
  • Klebsiella sp. and ampicillin
  • Proteus mirabilis and nitrofurantoin or colistin
  • Serratia marcescens and colistin

7
Exceptional phenotypes (usually resistance)
  • Resistance in a species where resistance has not
    been seen or is rare.
  • Resistant results should be viewed with caution
  • errors in identification or susceptibility
    testing
  • If resistance is confirmed send the isolate to a
    reference laboratory for independent confirmation
  • Exceptional resistance phenotypes may change with
    time
  • There may also be regional or national differences

8
Exceptional phenotype examples
  • S. pyogenes resistant to penicillin
  • S. aureus resistant to vancomycin
  • E. faecalis resistant to ampicillin
  • Enterobacteriaceae resistant to carbapenems
  • Anaerobes resistant to metronidazole
  • E. faecium susceptible to ampicillin

9
Interpretive reading
  • Test susceptibility
  • Infer resistance mechanism
  • Interpret clinical susceptibility on the basis of
    the resistance mechanism

10
Interpretive reading examples
  • may be simple e.g. ..IF S. aureus is resistant
    to oxacillin or cefoxitin
  • Resistance mechanism PBP2 mediated by mecA
  • THEN report resistant to all ß-lactams
  • or more complicated e.g.IF Enterobacteriaceae
    intermediate to tobramycin, resistant to
    gentamicin and susceptible to amikacin
  • Resistance mechanism ANT(2) enzyme - may be low
    expression and isolates may have decreased
    susceptibility to tobramycin.
  • THEN report resistant to tobramycin

11
Actions indicated by expert rules
  • Recommendations on reporting
  • Inference of susceptibility
  • Editing of results from S to I or R, from I to R,
    but NEVER I or R to S
  • Suppression of results
  • Addition of comments
  • Advice on further tests
  • Advice on referral of isolates

12
Requirements for use of expert rules in clinical
laboratories
  • Identify the organism fully
  • May need to test an extended range of appropriate
    antibiotics
  • Access to a set of expert rules

13
An expert system for susceptibility testing?
Human experts are rare and are not available in
most laboratories..
14
Expert systems for susceptibility testing are
computer based programs for application of expert
rules
  • Stand alone programs
  • Laboratory information systems
  • Programs linked to susceptibility testing devices
    and rules applied automatically to susceptibility
    results

15
EUCAST expert rules
  • Written description of current expert rules
  • Comprehensive collection of rules brought
    together by an expert subcommittee
  • May be applied manually or incorporated into
    automated systems

16
Development of EUCAST expert rules
  • First draft prepared by expert subcommittee
  • Consultation with EUCAST national breakpoint
    committees
  • Second draft for open consultation via EUCAST
    public website, EUCAST national breakpoint
    committees, EUCAST national representatives,
    industry networks and experts
  • Version 1 published April 2008
  • Will need to be updated regularly and validated
    for EUCAST breakpoints

17
Expert rules should be evidence based
  • Should be based on current evidence
  • Evidence should be published
  • Quality of evidence should be assessed
  • Exceptions should be noted

18
Grading of evidence base for EUCAST Expert rules
  • A There is clinical evidence that reporting the
    test result as susceptible leads to clinical
    failures.
  • B Evidence is weak and based only on a few case
    reports or on experimental models. It is presumed
    that reporting the test result as susceptible may
    lead to clinical failures.
  • C There is currently no clinical evidence, but
    microbiological data suggest that clinical use of
    the agent should be discouraged.

19
Presentation of EUCAST expert rules Intrinsic
resistances
Rule no. Organism Ampicillin Amoxicillin-clavulanate Ticarcillin Piperacillin Cefazolin Cefoxitin
1.1 Citrobacter koseri R R R
1.2 Citrobacter freundii R R R R
1.3 Enterobacter cloacae R R R R
1.4 Enterobacter aerogenes R R R R
20
Presentation of EUCAST expert rules Exceptional
phenotypes
Rule no. Organism Exceptional phenotype
6.1 Staphylococcus aureus Resistant to vancomycin, linezolid, quinupristin/dalfopristin, daptomycin, tigecycline.
6.2 Coagulase-negative staphylococci Resistant to vancomycin, linezolid, quinupristin/dalfopristin, daptomycin, tigecycline.
6.3 JK coryneform organisms Resistant to vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, daptomycin, tigecycline.
6.4 Streptococcus pneumoniae Resistant to imipenem, meropenem, vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, daptomycin, tigecycline, rifampicin.
21
Presentation of EUCAST expert rules
Interpretive reading rules for specific groups
of organisms
Rule no. Organism Agent Rule Exceptions Scientific basis Evidence grade References
8.1 Staphylococcus spp. Isoxazolyl-penicillins If resistant to isoxazolyl-penicillins (as determined with oxacillin or cefoxitin, or by detection of mecA-gene or PBP2a) report as resistant to all ß-lactams Developmental anti-MRSA cephalosporins, e.g. ceftobiprole and ceftaroline Production of PBP2a (encoded by mecA) leads to cross resistance to ß-lactams except ceftobiprole and ceftaroline A Chambers HF et al., 1990. Page MG et al., 2006.
22
Expert rules
  • EUCAST expert rules are an up-to-date and
    comprehensive collection of accumulated knowledge
    of intrinsic resistances, exceptional phenotypes
    and interpretive reading
  • It is intended that the rules will be applied to
    routine antimicrobial susceptibility tests and
    will make a significant contribution to the
    quality of reported results
Write a Comment
User Comments (0)
About PowerShow.com